5-[3-(Trifluoroacetyl amino)-prop-1-ynyl]-2'-desoxyuridin is a chemically modified nucleoside derivative. Its structure is based on 2'-deoxyuridine, featuring a 5-(3-trifluoroacetamidoprop-1-ynyl) substituent on the uracil base. This modification introduces an alkyne linker terminated with a trifluoroacetamide group, making it a valuable synthetic intermediate. This compound is primarily used in life science research and medicinal chemistry. The alkyne handle allows for site-specific conjugation via click chemistry (e.g., copper-catalyzed azide-alkyne cycloaddition), enabling the labeling or functionalization of nucleosides. It serves as a key building block for synthesizing modified nucleosides and nucleotides with potential antiviral or anticancer activities, particularly in the development of nucleoside analog prodrugs. As a specialized, functionalized nucleoside, it is not a general-purpose synthetic reagent. Its primary value lies in its role as a precursor for more complex bioactive molecules and as a tool for bioconjugation in probe development.